Freedom Biosciences
PrivateLast Round
Seed
Aug 23, 2022
Total Funding Raised
$10.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Freedom Biosciences operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in August 2022.
Freedom Biosciences is a clinical-stage biotechnology company that develops next-generation neuropsychiatric therapeutics, including ketamine-based and psychedelic-inspired treatments for mental health conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Freedom Biosciences Comparables
Compare Freedom Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gilgamesh Pharmaceuticals | 86% | |
| Reunion Neuroscience Inc. | 81% | |
| Delix Therapeutics | 79% |
For institutional investors. Book with your work email.
Freedom Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Freedom Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LongeVC | Seed |
| Village Global | Seed |
| Village Global | Seed |
| FundRx | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 133% MoM, reaching 1.7K.
- Apr 23, 2026
Monthly visitors grew 219% MoM, reaching 4.4K.
For institutional investors. Book with your work email.
Freedom Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Freedom Biosciences's valuation, stock price, and market status.
Is Freedom Biosciences a public or private company?
Freedom Biosciences is a private company.
What is the current stock price of Freedom Biosciences?
Freedom Biosciences is a private company, so its shares have no public market price. Caplight tracks Freedom Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Freedom Biosciences worth (valuation)?
Valuation information for Freedom Biosciences is not publicly available.
Can I buy Freedom Biosciences stock?
Freedom Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Freedom Biosciences's last funding round?
Freedom Biosciences's most recent funding round was Seed on August 23, 2022.
Who are the main investors in Freedom Biosciences?
Key investors in Freedom Biosciences include FundRx.
Will Freedom Biosciences IPO soon?
No public IPO plans have been announced for Freedom Biosciences.
How can I track Freedom Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Freedom Biosciences's shares on secondary markets.